Women's pill 'hope for prostate cancer'

A gene-targeting pill for women may provide a highly effective treatment for up to a third of men with advanced prostate cancer, trial results have shown.

Olaparib, the first marketed drug to tackle inherited cancer mutations, was licensed last year for women with ovarian cancer who have faulty BRCA genes.

The new trial, described as a "milestone" by the UK's Institute of Cancer Research, found

Latest

Trending